DNA/Gene Microarray Market

DNA/Gene Microarray Market, By Type (Oligonucleotide DNA Microarrays, Complementary DNA Microarrays),By Application (Genomics, Proteomics, Agricultural Biology, Environment, Drug Research and Development, Cancer/oncology, Others (SNP Analysis, etc.)),By End User (Biopharmaceutical and Pharmaceutical Companies, Diagnostic Laboratories, Research Laboratories, Others (Academic Institutes, etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

DNA chips, biochips, or DNA microarrays consist of a microscope slide made of materials such as glass, silicon chips, and nylon membrane, which is printed with thousands of minute spots. These spots contain a known DNA sequence or gene in an ordered sequence. DNA microarrays use the nucleic acid hybridization principle, and types of DNA microarrays include cDNA microarrays, oligo DNA microarrays, BAC microarrays, and SNP microarrays. Applications of DNA chips include the study of transcriptomes and proteomes, the diagnosis of diseases, the identification of microbes, and others. A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to genotype different areas of a genome or to assess the expression levels of several genes at once. The method is applicable to areas such as clinical diagnostics, agriculture, environmental management, and other fields.

Market Dynamics

The field of cancer research has made the most extensive use of DNA/gene microarrays, which combine biological data with statistical expertise to provide fresh perspectives on a variety of biological systems. A DNA/gene microarray, therefore, measures the levels of gene (mRNA) transcripts in a sample, and since thousands of gene fragments can be located on an array, it can provide a genome-wide view of gene expression in cancer. Thus, the increasing prevalence of cancer is expected to fuel market growth over the forecast period. For instance, in February 2021, according to the report published by Globocan, a worldwide database of cancer incidence and mortality rates, 19.3 million new cancer cases were reported worldwide in 2020. Female breast cancer had surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases globally in 2020, followed by lung, colorectal, prostate, and stomach cancers.

Furthermore, according to the Centers for Disease Control and Prevention, there were 1,603,844 new cancer cases and 602,347 people who died of cancer in the U.S. in 2020.

Key features of the study:

• This report provides an in-depth analysis of the global DNA/gene microarray market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global DNA/gene microarray market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Caliper Life Sciences, Perkin Elmer, Inc., PathogenDx, Inc., Twist Bioscience Corporation, Arraylt Corporation, Molecular Device, LLC and Raybiotech Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global DNA/gene microarray market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA/gene microarray market.

Detailed Segmentation:

• Global DNA/Gene Microarray Market, By Type:
• Oligonucleotide DNA Microarrays
• Complementary DNA Microarrays
• Global DNA/Gene Microarray Market, By Application:
• Genomics
• Proteomics
• Agricultural Biology
• Environment
• Drug Research and Development
• Cancer/oncology
• Others (SNP Analysis, etc.)
• Global DNA/Gene Microarray Market, By End User:
• Biopharmaceutical and Pharmaceutical Companies
• Diagnostic Laboratories
• Research Laboratories
• Others (Academic Institutes, etc.)
• Global DNA/Gene Microarray Market, By Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
• Company Profiles
• Affymetrix, Inc.
• Illumina, Inc.
• Agilent Technologies Inc.
• Roche NimbleGen Inc.
• Sequenom, Inc.
• Biometrix Technology Inc.
• LC Sciences
• Life Technologies Corp.
• Lifegen Technologies LLC
• Microarrays Inc.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Caliper Life Sciences
• Perkin Elmer, Inc.
• PathogenDx, Inc.
• Twist Bioscience Corporation
• Arraylt Corporation
• Molecular Device, LLC
• Raybiotech Inc.